Active, not recruitingPhase 4NCT05680415

Clinical Trial of Mica

Studying Tuberculosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
Principal Investigator
Yi Mo, Master
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Intervention
Mycobacterium Vaccae for Injection(biological)
Enrollment
6800 enrolled
Eligibility
15 years · All sexes
Timeline
2023 – 2027

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05680415 on ClinicalTrials.gov

Other trials for Tuberculosis

Additional recruiting or active studies for the same condition.

See all trials for Tuberculosis →

← Back to all trials